CDH17 and head and neck squamous cell carcinoma: Notably, MB21D2 is the only cadherin‐binding gene with a recurrent mutation rate larger than 20% detected in two SCCs, including head and neck squamous cell carcinoma (HNSCC: 41.66%) and lung squamous cell carcinoma (LUSC: 38.46%) (Fig. 1B).